Winter 2024 Investor Summit Virtual
Conventional imaging and diagnostics provide valuable structural information but struggle to identify the source of the pathogenic pain.
Low surgical success rates (41-57%)2,3 especially for patients suffering from Discogenic Chronic Low Back Pain (DCLP).
Of all the disease states, low back and neck pain account for the highest healthcare spending in US.1
Aclarion is a healthcare technology company focused on advancing the care of patients by combining the imaging capabilities of magnetic resonance spectroscopy (MRS) with a proprietary, augmented-intelligence algorithm to noninvasively deliver SaaS solutions that help physicians personalize treatment plans to support improved clinical outcomes and return patients to full, pain-free lives. The company’s first solution will address unmet needs in the low back and neck pain market